Back to Type 2 Diabetes
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT01726621

NCT01726621
Completed Not Applicable 🇦🇺 Australian site

Who may be able to join

Who might be able to join this trial:

  • You must be 7 years old or older at the time of screening
  • You must have been using an insulin pump for at least 3 months
  • You must be experienced with continuous glucose monitoring, meaning you can insert and change the sensor yourself, recharge the transmitter, and read your glucose data in real-time on your pump screen
  • You must be willing to sign a consent form and follow the study procedures
  • You must be willing to fill out questionnaires throughout the study
  • You must have been diagnosed with either Type 1 diabetes or insulin-dependent Type 2 diabetes for at least 6 months before joining

Who may not be able to join:

  • Women who test positive on a urine pregnancy test
  • Women who plan to become pregnant during the study (and if pregnancy occurs during the study, the participant would need to leave)
  • Anyone who has a condition that the study doctor feels could prevent them from safely participating or completing the study (confirm with trial site)
  • Anyone with vision or hearing difficulties that could make it hard to use the study device, as assessed by the study doctor
  • Anyone who is currently taking part in another clinical trial involving an experimental drug or device, or has done so within the last 2 weeks

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Medtronic MiniMed, Inc.
Registry
clinicaltrials_gov
Start date
1 March 2013
Est. completion
1 November 2014

Where this trial is recruiting

🇦🇺 Australia 🇩🇰 Denmark 🇪🇸 Spain 🇬🇧 United Kingdom

2 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

User Acceptance of the New MiniMed 620G and 640G Insulin Pumps and Guardian Link Transmitter

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov